Market research
NMVA.F Captor Capital Corp
F EUR Healthcare
Latest close
Latest stored close unavailable
Test a moving-average rule with historical data.
Market facts
- Market cap
- 16M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- 0.0%
- Beta
- 0.36
Profile
Instrument facts
- Exchange
- F
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- ISIN
- CA14075H2028
- Market cap
- 16M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- 0.0%
- Beta
- 0.36
About
About Captor Capital Corp
Captor Capital Corp. engages in the manufacture and retail sale of cannabis products in the United States. The company owns and operates a retail chain of nine dispensaries in California, including Santa Cruz, Antioch, El Sobrante, Salinas, Lompoc, Goleta, Atwater, Palm Springs, and Castroville under the One Plant brand name. It also operates an e-commerce site under One Plant brand. The company was formerly known as NWT Uranium Corp. and changed its name to Captor Capital Corp. in June 2, 2017. Captor Capital Corp. was incorporated in 2003 and is based in Toronto, Canada.
Research context
Captor Capital Corp appears in PyInvesting’s Frankfurt Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the NMVA.F discussion.
5 years, 7 months ago
Captor Capital Corp is currently in a long term uptrend where the price is trading 87.4% above its 200 day moving average.
From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.2.
Captor Capital Corp's total revenue rose by 99.0% to $4M since the same quarter in the previous year.
Its net income has increased by 92.4% to $-825K since the same quarter in the previous year.
Finally, its free cash flow grew by 42.8% to $-2M since the same quarter in the previous year.
Based on the above factors, Captor Capital Corp gets an overall score of 5/5.